Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC

Company Name

PENDOPHARM DIVISION OF PHARMASCIENCE INC

Totals

Shortage reports

129

Actual shortage: 2 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (4%)
Resolved: 122 (95%)

Discontinuation Reports

3

To be discontinued: 0 (0%)
Discontinued: 2 (67%)
Reversed: 1 (33%)

Late reports

17 (13%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SOLYSTAT 250MG SUSPENSION Resolved 2025-03-10 2025-05-09 252253
SOLYSTAT 250MG SUSPENSION Resolved 2025-05-06 2025-08-11 256751
PDP-AMLODIPINE 1MG SOLUTION Resolved 2023-06-23 2023-08-24 196318
PDP-LEVETIRACETAM 100MG SOLUTION Resolved 2019-12-06 2020-03-06 100451
PDP-LEVETIRACETAM 100MG SOLUTION Resolved 2021-05-21 2021-07-09 139814
DEMYLOCAN 50MG POWDER Resolved 2021-06-08 2021-06-22 140576
PDP-LEVETIRACETAM 100MG SOLUTION Resolved 2020-09-25 2020-10-06 125104
PDP-LEVETIRACETAM 100MG SOLUTION Resolved 2021-01-29 2021-04-22 132789
MYINFLA 0.5MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-11 2025-05-08 239848

Showing 121 to 129 of 129

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
IBAVYR 400MG TABLET Discontinued 2023-01-20 2023-01-20 182029
IBAVYR 200MG TABLET Discontinued 2023-01-20 2023-01-20 182060
OCPHYL 500MCG SOLUTION Reversed 2017-04-10 2017-04-10 6237

Showing 1 to 3 of 3